Search
Displaying 331–340 of 585 for “Retinitis pigmentosa”
-
RP Treatment Derived from Induced Pluripotent Stem Cells Advances into Clinical Trial
Research NewsThe stem cells were derived from mature blood cells and coaxed to become photoreceptors
-
Foundation Fighting Blindness to Host Fall National Virtual VisionWalk
Foundation NewsThe Virtual VisionWalk on October 24th will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
The Dutterers Aren't Afraid to Share Their Story
Beacon StoriesSteve and Dot Dutterer have kind and approachable personalities that captivate everyone they meet. With their expansive network, and a lot of hard work and dedication over the past 19 years, Steve and Dot have raised more than $743,000 for the Foundation through the Baltimore VisionWalk.
-
My Retina Tracker Program and Registry Featured in American Journal of Medical Genetics
Research NewsThe paper provides insights into the genetic landscape of inherited retinal diseases
-
4D Molecular Therapeutics Launches Phase 1 Clinical Trial for Choroideremia Gene Therapy
Research NewsGene therapy delivered by intravitreal injection
-
jCyte Reports Promising Results for Phase 2b Clinical Trial of its Cellular Therapy for RP
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing vision loss
-
AGTC Planning Phase 2/3 Clinical Trial for XLRP Gene Therapy
Research NewsThe company is also expanding its Phase ½ trial for the emerging treatment
-
Research News
A Phase 3 trial for the treatment is planned
-
Bionic Sight Doses First Patient in Clinical Trial for Optogenetic Therapy
Research NewsTreatment combines gene therapy and a device that generates and delivers retinal code
-
Abfero Targeting Excess Iron to Treat AMD, Other Retinal Diseases
Partner NewsAn intriguing link between excess body iron and retinal degeneration is being explored by Abfero Pharmaceuticals, a young biotech based in Boston and Oxford, UK.
